<SUBMISSION>
<SECRELEASE-DATETIME> 20200128-093333 ⇐ Metadata from SEC Info (ET)
<SECWEBSITE-DATETIME> 20200128-093333 ⇐ Metadata from SEC Info (ET)
<ACCEPTANCE-DATETIME> 20200128-093241 ⇐ Filing accepted by SEC (ET)
<ACCESSION-NUMBER> 0001354457-20-000034
<TYPE> 25-NSE
<PUBLIC-DOCUMENT-COUNT> 2
<FILING-DATE> 20200128
<DATE-OF-FILING-DATE-CHANGE> 20200128
<EFFECTIVENESS-DATE> 20200128
|
<SUBJECT-COMPANY>
<COMPANY-DATA>
<CONFORMED-NAME> ACHILLION PHARMACEUTICALS INC
<CIK> 0001070336
<ASSIGNED-SIC> 2834
<IRS-NUMBER> 000000000
<STATE-OF-INCORPORATION> DE
<FISCAL-YEAR-END> 1231
</COMPANY-DATA>
<FILING-VALUES>
<FORM-TYPE> 25-NSE
<ACT> 34
<FILE-NUMBER> 001-33095
<FILM-NUMBER> 20551726
</FILING-VALUES>
<BUSINESS-ADDRESS>
<STREET1> 300 GEORGE STREET
<CITY> NEW HAVEN
<STATE> CT
<ZIP> 06511
<PHONE> 203-624-7000
</BUSINESS-ADDRESS>
<MAIL-ADDRESS>
<STREET1> 300 GEORGE STREET
<CITY> NEW HAVEN
<STATE> CT
<ZIP> 06511
</MAIL-ADDRESS>
</SUBJECT-COMPANY>
|
<FILED-BY>
<COMPANY-DATA>
<CONFORMED-NAME> The Nasdaq Stock Market LLC
<CIK> 0001354457
<IRS-NUMBER> 521165937 ⇒ 52-1165937 or 521-16-5937
<STATE-OF-INCORPORATION> DE
<FISCAL-YEAR-END> 1231
</COMPANY-DATA>
<FILING-VALUES>
<FORM-TYPE> 25-NSE
</FILING-VALUES>
<BUSINESS-ADDRESS>
<STREET1> One Liberty Plaza
<CITY> New York
<STATE> NY
<ZIP> 10006
<PHONE> 301-978-4144
</BUSINESS-ADDRESS>
<MAIL-ADDRESS>
<STREET1> Office of General Counsel
<STREET2> 805 King Farm Blvd.
<CITY> ROCKVILLE
<STATE> MD
<ZIP> 20850
</MAIL-ADDRESS>
</FILED-BY>
|
<DOCUMENT>
<TYPE> 25-NSE
<SEQUENCE> 1
<FILENAME> primary_doc.xml
<TEXT>
<XML>
<?xml version="1.0"?>
Show <XML>: 37 lines (widest: 69 characters) - 2K bytes
</TEXT>
</DOCUMENT>
|
<DOCUMENT>
<TYPE> EX-99.25
<SEQUENCE> 2
<FILENAME> achn-form25.txt
<TEXT>
Show <TEXT>: 1 lines (widest: 11 characters) - 12 bytes
</TEXT>
</DOCUMENT>
|
</SUBMISSION> |
| ↑Top |
